A virtual conference from the Wellcome Genome Campus, 'Immunogenomics of Disease: Accelerating to Patient Benefit' will take place on 10-12 February 2021.
This conference aims to bring together scientists working in molecular immunology, functional genomics and immune-mediated disease genetics to showcase recent findings in the field of immunogenomics. It will also explore ways to implement the genetic discoveries to benefit patient health.
Our understanding of immune cell function has benefited greatly from advances in next generation sequencing and the genetic characterisation of immune cells has become a powerful tool to understand adaptive and innate immunity. Genetic variants in host immune cells and cancer cells are being identified that prove pivotal in the elucidation of the susceptibility to various immune diseases and to the development of personalised treatment. To accelerate the translation of these discoveries into the clinic, we urgently need to improve our understanding of the molecular consequences of disease-associated variants, immunological processes and drug target discovery.
The meeting aims at highlighting the importance of high quality genomic data in a diverse range of topics including mono-and polygenic traits in immunity, the role of the microbiome in immune responses and epigenetic mechanisms. It will also emphasise the translation of genetic information into clinical routine and therapeutic approaches to aid patient benefit.
- Abstract deadline: 5 January 2021
- Registration deadline: 3 February 2021